Acasti Pharma Inc - Class A (ACST) Company Profile & Statistics

Acasti Pharma Inc - Class A
ACST
(Nasdaq - US)
N/A
2.80
+0.10 (+3.70%)
in:usd•As of: May 16, 2024 12:01 UTC -4
Open
2.80
High
2.80
Low
2.80

About Acasti Pharma Inc - Class A

CEO

Prashant Kohli

Headquarters

3009, boul. de la concorde east, suite 102

laval, a8 h7e 2b5, canada

Auditor

KPMG LLP

Employees

N/A

Share Holders

Website

www.acastipharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.

Acasti Pharma Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	26.22M
Enterprise Value	7.67M
Enterprise Value/EBITDA (ttm)	-0.16
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.41
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-13.18%
Return on Invested Capital (ttm)	-57.69%
Return on Assets (ttm)	-11.32%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-47.64M
Net Income Avi to Common (ttm)	-38.77M
Diluted EPS (ttm)	-5.08

Share Statistics

Beta (5Y Monthly)	1.55
52-Week Change	-9.39%
S&P500 52-Week Change	29.22%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	9.40M
Dividend Yield	0.00%
Float ⁴	8.13M
% Held by Insiders	13.51%
% Held by Institutions	6.08%

Balance Sheet

Total Cash (mrq)	25.11M
Total Cash Per Share (mrq)	2.67
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	15.19%
Quick Ratio (mrq)	15.19%
Book Value Per Share (mrq)	6.88

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.89
Free Cash Flow (ytd)	-10.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Acasti Pharma Inc - Class A

Trade With A Regulated Broker